Patent · US Active

Methods for distinguishing between lung squamous carcinoma and other non small cell lung cancers

US8563252B2 · kind B2 · utility

0Cited by
2References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 31, 2009
Grant dateOct 22, 2013
Priority date
Expiry dateAug 17, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/178
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides nucleic acid sequences that are used for identification, classification and diagnosis of specific types of nonsmall-cell lung cancers (NSCLC). The nucleic acid sequences can also be used for prognosis evaluation of a subject based on the expression pattern of a biological sample.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.